Healthcare entity
BioLife Solutions is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Source depth averages 11.5 original sources per story, versus 4 across the same-window beat baseline. Their average consequence score of 6 runs above the beat's 5.7 for that window.
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
BioLife Solutions is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Source depth averages 11.5 original sources per story, versus 4 across the same-window beat baseline. Their average consequence score of 6 runs above the beat's 5.7 for that window. market-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Butterfly Network appears in 2 tracked Healthcare stories published from February 25, 2026 through February 27, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 101 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Butterfly Network. Shared-story counts are live from our verified record — not editorial picks.
The fourth quarter of 2025 revealed a decisive shift in the healthcare technology sector toward AI-integrated diagnostics and high-margin specialized therapies. Leading the charge, Butterfly Network reported record revenue growth driven by its AI-embedded strategy, while Solventum navigated its post-spin-off stabilization phase with resilient organic growth.
Delcath Systems, Lantheus Holdings, Butterfly Network, and Heron Therapeutics are preparing to report Q4 2025 earnings, marking a critical test for commercial-stage medical innovators. Investors are laser-focused on the adoption rates of flagship products like HEPZATO KIT and PYLARIFY as these companies navigate a complex reimbursement environment.
Source: Seeking Alpha · Seeking Alpha
Butterfly Network is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
